Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus

Robert B. Conley, Dane Dickson, Jean Claude Zenklusen, Jennifer Al Naber, Donna A. Messner, Ajlan Atasoy, Lena Chaihorsky, Deborah Collyar, Carolyn Compton, Martin Ferguson, Sean Khozin, Roger D. Klein, Sri Kotte, Razelle Kurzrock, C. Jimmy Lin, Frank Liu, Ingrid Marino, Robert McDonough, Amy McNeal, Vincent MillerRichard L. Schilsky, Lisa I. Wang

Research output: Contribution to journalComment/debate

3 Citations (Scopus)

Abstract

The Center for Medical Technology Policy and the Molecular Evidence Development Consortium gathered a diverse group of more than 50 stakeholders to develop consensus on a core set of data elements and values essential to understanding the clinical utility of molecularly targeted therapies in oncology. The Center for Medical Technology Policy and the Molecular Evidence Development Consortium gathered a diverse group of more than 50 stakeholders to develop consensus on a core set of data elements and values essential to understanding the clinical utility of molecularly targeted therapies in oncology.

Original languageEnglish (US)
Pages (from-to)982-986
Number of pages5
JournalCell
Volume171
Issue number5
DOIs
StatePublished - Nov 16 2017

Fingerprint

Oncology
Technology
Neoplasms
Therapeutics
Datasets

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Conley, R. B., Dickson, D., Zenklusen, J. C., Al Naber, J., Messner, D. A., Atasoy, A., ... Wang, L. I. (2017). Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus. Cell, 171(5), 982-986. https://doi.org/10.1016/j.cell.2017.10.032

Core Clinical Data Elements for Cancer Genomic Repositories : A Multi-stakeholder Consensus. / Conley, Robert B.; Dickson, Dane; Zenklusen, Jean Claude; Al Naber, Jennifer; Messner, Donna A.; Atasoy, Ajlan; Chaihorsky, Lena; Collyar, Deborah; Compton, Carolyn; Ferguson, Martin; Khozin, Sean; Klein, Roger D.; Kotte, Sri; Kurzrock, Razelle; Lin, C. Jimmy; Liu, Frank; Marino, Ingrid; McDonough, Robert; McNeal, Amy; Miller, Vincent; Schilsky, Richard L.; Wang, Lisa I.

In: Cell, Vol. 171, No. 5, 16.11.2017, p. 982-986.

Research output: Contribution to journalComment/debate

Conley, RB, Dickson, D, Zenklusen, JC, Al Naber, J, Messner, DA, Atasoy, A, Chaihorsky, L, Collyar, D, Compton, C, Ferguson, M, Khozin, S, Klein, RD, Kotte, S, Kurzrock, R, Lin, CJ, Liu, F, Marino, I, McDonough, R, McNeal, A, Miller, V, Schilsky, RL & Wang, LI 2017, 'Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus', Cell, vol. 171, no. 5, pp. 982-986. https://doi.org/10.1016/j.cell.2017.10.032
Conley RB, Dickson D, Zenklusen JC, Al Naber J, Messner DA, Atasoy A et al. Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus. Cell. 2017 Nov 16;171(5):982-986. https://doi.org/10.1016/j.cell.2017.10.032
Conley, Robert B. ; Dickson, Dane ; Zenklusen, Jean Claude ; Al Naber, Jennifer ; Messner, Donna A. ; Atasoy, Ajlan ; Chaihorsky, Lena ; Collyar, Deborah ; Compton, Carolyn ; Ferguson, Martin ; Khozin, Sean ; Klein, Roger D. ; Kotte, Sri ; Kurzrock, Razelle ; Lin, C. Jimmy ; Liu, Frank ; Marino, Ingrid ; McDonough, Robert ; McNeal, Amy ; Miller, Vincent ; Schilsky, Richard L. ; Wang, Lisa I. / Core Clinical Data Elements for Cancer Genomic Repositories : A Multi-stakeholder Consensus. In: Cell. 2017 ; Vol. 171, No. 5. pp. 982-986.
@article{aa7433dcfb0743a7931bc580cfb955bb,
title = "Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus",
abstract = "The Center for Medical Technology Policy and the Molecular Evidence Development Consortium gathered a diverse group of more than 50 stakeholders to develop consensus on a core set of data elements and values essential to understanding the clinical utility of molecularly targeted therapies in oncology. The Center for Medical Technology Policy and the Molecular Evidence Development Consortium gathered a diverse group of more than 50 stakeholders to develop consensus on a core set of data elements and values essential to understanding the clinical utility of molecularly targeted therapies in oncology.",
author = "Conley, {Robert B.} and Dane Dickson and Zenklusen, {Jean Claude} and {Al Naber}, Jennifer and Messner, {Donna A.} and Ajlan Atasoy and Lena Chaihorsky and Deborah Collyar and Carolyn Compton and Martin Ferguson and Sean Khozin and Klein, {Roger D.} and Sri Kotte and Razelle Kurzrock and Lin, {C. Jimmy} and Frank Liu and Ingrid Marino and Robert McDonough and Amy McNeal and Vincent Miller and Schilsky, {Richard L.} and Wang, {Lisa I.}",
year = "2017",
month = "11",
day = "16",
doi = "10.1016/j.cell.2017.10.032",
language = "English (US)",
volume = "171",
pages = "982--986",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Core Clinical Data Elements for Cancer Genomic Repositories

T2 - A Multi-stakeholder Consensus

AU - Conley, Robert B.

AU - Dickson, Dane

AU - Zenklusen, Jean Claude

AU - Al Naber, Jennifer

AU - Messner, Donna A.

AU - Atasoy, Ajlan

AU - Chaihorsky, Lena

AU - Collyar, Deborah

AU - Compton, Carolyn

AU - Ferguson, Martin

AU - Khozin, Sean

AU - Klein, Roger D.

AU - Kotte, Sri

AU - Kurzrock, Razelle

AU - Lin, C. Jimmy

AU - Liu, Frank

AU - Marino, Ingrid

AU - McDonough, Robert

AU - McNeal, Amy

AU - Miller, Vincent

AU - Schilsky, Richard L.

AU - Wang, Lisa I.

PY - 2017/11/16

Y1 - 2017/11/16

N2 - The Center for Medical Technology Policy and the Molecular Evidence Development Consortium gathered a diverse group of more than 50 stakeholders to develop consensus on a core set of data elements and values essential to understanding the clinical utility of molecularly targeted therapies in oncology. The Center for Medical Technology Policy and the Molecular Evidence Development Consortium gathered a diverse group of more than 50 stakeholders to develop consensus on a core set of data elements and values essential to understanding the clinical utility of molecularly targeted therapies in oncology.

AB - The Center for Medical Technology Policy and the Molecular Evidence Development Consortium gathered a diverse group of more than 50 stakeholders to develop consensus on a core set of data elements and values essential to understanding the clinical utility of molecularly targeted therapies in oncology. The Center for Medical Technology Policy and the Molecular Evidence Development Consortium gathered a diverse group of more than 50 stakeholders to develop consensus on a core set of data elements and values essential to understanding the clinical utility of molecularly targeted therapies in oncology.

UR - http://www.scopus.com/inward/record.url?scp=85034103971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034103971&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2017.10.032

DO - 10.1016/j.cell.2017.10.032

M3 - Comment/debate

C2 - 29149611

AN - SCOPUS:85034103971

VL - 171

SP - 982

EP - 986

JO - Cell

JF - Cell

SN - 0092-8674

IS - 5

ER -